Why This Matters: When global supply chains falter, Canadian patients can face drug delays or cost increases. A resilient system means better access, less disruption, and fewer surprises in care.
In this BBC article, readers are taken behind the scenes of global medicine production and supply to better understand why shortages, delays, and rising drug costs are becoming more common. Several factors contribute to this, including pandemic-era disruptions, raw-material scarcity, older manufacturing infrastructure, and trade restrictions. While the focus is global, the article underscores that Canada is not immune to these pressures and must strengthen its systems to ensure patients don’t face unexpected gaps in treatment.